Skip to main content

Advertisement

SpringerLink
Log in

Novel therapeutic approaches for progressive renal disorders by targeting glomerular component mesangial and endothelial cells

  • REVIEW ARTICLE
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. LJ Striker EP Peten SJ Elliot T Doi GE Striker (1991) ArticleTitleMesangial cell turnover: effect of heparin and peptide growth factors Lab Invest 64 446–56 Occurrence Handle1:CAS:528:DyaK3MXltlarsbg%3D Occurrence Handle2016850

    CAS  PubMed  Google Scholar 

  2. S Klahr G Schreiner I Ichikawa (1988) ArticleTitleThe progression of renal disease N Engl J Med 318 1657–66 Occurrence Handle1:STN:280:DyaL1c3jt1ygsg%3D%3D Occurrence Handle3287163 Occurrence Handle10.1056/NEJM198806233182505

    Article  CAS  PubMed  Google Scholar 

  3. J Floege E Eng BA Young RJ Johnson (1993) ArticleTitleFactors involved in the regulation of mesangial cell proliferation in vitro and in vivo Kidney Int 43 S47–54 Occurrence Handle10.1038/ki.1993.55

    Article  Google Scholar 

  4. PJ Shultz PE DiCorleto BJ Silver HE Abboud (1988) ArticleTitleMesangial cells express PDGF mRNAs and proliferate in response to PDGF Am J Physiol 255 F674–84 Occurrence Handle1:CAS:528:DyaL1cXmtVGlu7s%3D Occurrence Handle2845810 Occurrence Handle10.1152/ajpcell.1988.255.5.C674

    Article  CAS  PubMed  Google Scholar 

  5. J Floege E Eng BA Young CE Alpers TB Barrett DF Bowen-Pope et al. (1993) ArticleTitleInfusion of platelet-derived growth factor or basic fibroblast growth factor induces selective glomerular mesangial cell proliferation and matrix accumulation in rats J Clin Invest 92 2952–62 Occurrence Handle1:CAS:528:DyaK2cXltFOmsQ%3D%3D Occurrence Handle7902849 Occurrence Handle288499 Occurrence Handle10.1172/JCI116918

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. F Abbott JJ Ryan M Ceska K Matsushima CE Sarraf AJ Rees (1991) ArticleTitleInterleukin-1 beta stimulates human mesangial cells to synthesize and release interleukins-6 and -8 Kidney Int 40 597–605 Occurrence Handle1:CAS:528:DyaK38XkvFyj Occurrence Handle1745007 Occurrence Handle10.1038/ki.1991.250

    Article  CAS  PubMed  Google Scholar 

  7. N Kashihara Y Watanabe H Makino YS Kanwar (1992) ArticleTitleInterleukin-1-induced alterations in glomerular proteoglycans: biochemical and tissue autoradiographic aspects J Am Soc Nephrol 3 203–13 Occurrence Handle1:CAS:528:DyaK38XmtFSnsbk%3D Occurrence Handle1391721

    CAS  PubMed  Google Scholar 

  8. C Ruef K Budde J Lacy W Northemann M Baumann RB Sterzel et al. (1990) ArticleTitleInterleukin 6 is an autocrine growth factor for mesangial cells Kidney Int 38 249–57 Occurrence Handle1:CAS:528:DyaK3cXlslSisbs%3D Occurrence Handle2402117 Occurrence Handle10.1038/ki.1990.193

    Article  CAS  PubMed  Google Scholar 

  9. RJ Johnson E Raines J Floege A Yoshimura P Pritzl C Alpers et al. (1992) ArticleTitleInhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet derived growth factor J Exp Med 175 1413–16 Occurrence Handle1:CAS:528:DyaK38XhvFajt7w%3D Occurrence Handle1569407 Occurrence Handle10.1084/jem.175.5.1413

    Article  CAS  PubMed  Google Scholar 

  10. C Helene JJ Toulme (1990) ArticleTitleSpecific regulation of gene expression by antisense, sense and antigene nucleic acids Biochim Biophys Acta 1049 99–125 Occurrence Handle1:CAS:528:DyaK3cXltFSjs7o%3D Occurrence Handle1694695 Occurrence Handle10.1016/0167-4781(90)90031-V

    Article  CAS  PubMed  Google Scholar 

  11. M Simons ER Edelman JL DeKeyser R Langer RD Rosenberg (1992) ArticleTitleAntisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo Nature 359 67–70 Occurrence Handle1:CAS:528:DyaK3sXit1Ghsr8%3D Occurrence Handle1522889 Occurrence Handle10.1038/359067a0

    Article  CAS  PubMed  Google Scholar 

  12. R Morishita GH Gibbons KE Ellison M Nakajima L Zhang Y Kaneda et al. (1993) ArticleTitleSingle intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia Proc Natl Acad Sci USA 90 8474–8 Occurrence Handle1:CAS:528:DyaK2cXjtlE%3D Occurrence Handle8104336 Occurrence Handle47379 Occurrence Handle10.1073/pnas.90.18.8474

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. G Prelich CK Tan M Kostura MB Mathews AG So KM Downey et al. (1992) ArticleTitleFunctional identity of proliferating cell nuclear antigen and a DNA polymerased auxiliary protein Nature 326 517–20 Occurrence Handle10.1038/326517a0

    Article  Google Scholar 

  14. D Jaskulski C Gatti S Travali B Calabretta R Baserga (1988) ArticleTitleRegulation of the proliferating cell nuclear antigen cyclin and thymidine kinase mRNA levels by growth factors J Biol Chem 263 10175–9 Occurrence Handle1:CAS:528:DyaL1cXkvVOgurw%3D Occurrence Handle2899075

    CAS  PubMed  Google Scholar 

  15. C Schluter M Duchrow C Wohlenberg MH Becker G Key HD Flad et al. (1993) ArticleTitleThe cell proliferation-associated antigen of antibody Ki-67: a very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle-maintaining proteins J Cell Biol 123 513–22 Occurrence Handle1:STN:280:DyaK2c%2FktlCgtw%3D%3D Occurrence Handle8227122 Occurrence Handle10.1083/jcb.123.3.513

    Article  CAS  PubMed  Google Scholar 

  16. Y Maeshima N Kashihara H Sugiyama H Makino Z Ota (1996) ArticleTitleAntisense oligonucleotides to proliferating cell nuclear antigen and Ki-67 inhibit human mesangial cell proliferation J Am Soc Nephrol 7 2219–29 Occurrence Handle1:CAS:528:DyaK28XntVyqs7w%3D Occurrence Handle8915983

    CAS  PubMed  Google Scholar 

  17. K Thalmeier H Synovzik R Mertz EL Winnacker M Lipp (1989) ArticleTitleNuclear factor E2F mediates basic transcription and trans-activation by E1a of the human MYC promoter Genes Dev 3 527–36 Occurrence Handle1:CAS:528:DyaL1MXktlCntbc%3D Occurrence Handle2721961 Occurrence Handle10.1101/gad.3.4.527

    Article  CAS  PubMed  Google Scholar 

  18. S Dalton (1992) ArticleTitleCell cycle regulation of the human cdc2 gene EMBO J 11 1797–804 Occurrence Handle1:CAS:528:DyaK38XktVait70%3D Occurrence Handle1582409 Occurrence Handle556637

    CAS  PubMed  PubMed Central  Google Scholar 

  19. T Chittenden DM Livingston WG Kaelin SuffixJr (1991) ArticleTitleThe T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein Cell 65 1073–82 Occurrence Handle1:CAS:528:DyaK3MXkvVOktrY%3D Occurrence Handle1828394 Occurrence Handle10.1016/0092-8674(91)90559-H

    Article  CAS  PubMed  Google Scholar 

  20. RJ Watson PJ Dyson J McMahon (1987) ArticleTitleMultiple c-myb transcript cap sites are variously utilized in cells of mouse haemopoietic origin EMBO J 6 1643–51 Occurrence Handle1:CAS:528:DyaL2sXktlOhsLc%3D Occurrence Handle3608990 Occurrence Handle553537

    CAS  PubMed  PubMed Central  Google Scholar 

  21. N Kashihara Y Maeshima H Makino (1997) ArticleTitleTherapeutic intervention in glomerulonephritis by oligonucleotides Exp Nephrol 5 126–31 Occurrence Handle1:CAS:528:DyaK2sXis1KksLw%3D Occurrence Handle9108994

    CAS  PubMed  Google Scholar 

  22. N Tomita R Morishita J Higaki T Ogihara (1997) ArticleTitleA novel strategy for gene therapy and gene regulation analysis using transcription factor decoy oligonucleotides Exp Nephrol 5 429–34 Occurrence Handle1:CAS:528:DyaK2sXnt1Kqtrs%3D Occurrence Handle9386980

    CAS  PubMed  Google Scholar 

  23. Y Maeshima N Kashihara T Yasuda H Sugiyama T Sekikawa K Okamoto et al. (1998) ArticleTitleInhibition of mesangial cell proliferation by E2F decoy oligodeoxy nucleotide in vitro and in vivo J Clin Invest 101 2589–97 Occurrence Handle9616230 Occurrence Handle508848 Occurrence Handle10.1172/JCI429

    Article  PubMed  PubMed Central  Google Scholar 

  24. H Kawachi T Oite F Shimizu (1993) ArticleTitleQuantitative study of mesangial injury with proteinuria induced by monoclonal antibody 1-22-3 Clin Exp Immunol 92 342–6 Occurrence Handle1:STN:280:DyaK3s3ltFOisw%3D%3D Occurrence Handle8485919 Occurrence Handle1554806 Occurrence Handle10.1111/j.1365-2249.1993.tb03402.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. N Tomita M Horiuchi S Tomita GH Gibbons JY Kim D Baran et al. (1998) ArticleTitleAn oligonucleotide decoy for transcription factor E2F inhibits mesangial cell proliferation in vitro Am J Physiol 275 F278–84 Occurrence Handle1:CAS:528:DyaK1cXlsVyju7w%3D Occurrence Handle9691019 Occurrence Handle10.1152/ajpcell.1998.275.1.C278

    Article  CAS  PubMed  Google Scholar 

  26. R Kalluri VP Sukhatme (2000) ArticleTitleFibrosis and angiogenesis Curr Opin Nephrol Hypertens 9 413–18 Occurrence Handle1:STN:280:DC%2BD3M%2FhslGhsg%3D%3D Occurrence Handle10926178 Occurrence Handle10.1097/00041552-200007000-00013

    Article  CAS  PubMed  Google Scholar 

  27. R Timpl (1996) ArticleTitleMacromolecular organization of basement membranes Curr Opin Cell Biol 8 618–24 Occurrence Handle1:CAS:528:DyaK28Xmt12nsLo%3D Occurrence Handle8939648 Occurrence Handle10.1016/S0955-0674(96)80102-5

    Article  CAS  PubMed  Google Scholar 

  28. M Hangai N Kitaya J Xu CK Chan JJ Kim Z Werb et al. (2002) ArticleTitleMatrix metalloproteinase-9-dependent exposure of a cryptic migratory control site in collagen is required before retinal angiogenesis Am J Pathol 161 1429–37 Occurrence Handle1:CAS:528:DC%2BD38Xotl2jsbY%3D Occurrence Handle12368215 Occurrence Handle1867273 Occurrence Handle10.1016/S0002-9440(10)64418-5

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. PC Brooks RA Clark DA Cheresh (1994) ArticleTitleRequirement of vascular integrin alpha v beta 3 for angiogenesis Science 264 569–71 Occurrence Handle1:CAS:528:DyaK2cXjt1Sis7w%3D Occurrence Handle7512751 Occurrence Handle10.1126/science.7512751

    Article  CAS  PubMed  Google Scholar 

  30. PC Brooks AM Montgomery M Rosenfeld RA Reisfeld T Hu G Klier et al. (1994) ArticleTitleIntegrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels Cell 79 1157–64 Occurrence Handle1:CAS:528:DyaK2MXivVWqu7o%3D Occurrence Handle7528107 Occurrence Handle10.1016/0092-8674(94)90007-8

    Article  CAS  PubMed  Google Scholar 

  31. BL Bader H Rayburn D Crowley RO Hynes (1998) ArticleTitleExtensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins Cell 95 507–19 Occurrence Handle1:CAS:528:DyaK1cXns1ektrY%3D Occurrence Handle9827803 Occurrence Handle10.1016/S0092-8674(00)81618-9

    Article  CAS  PubMed  Google Scholar 

  32. KM Hodivala-Dilke KP McHugh DA Tsakiris H Rayburn D Crowley M Ullman-Cullere et al. (1999) ArticleTitleBeta3-integrin-deficient mice are a model for Glanzmann thrombasthenia showing placental defects and reduced survival J Clin Invest 103 229–38 Occurrence Handle1:CAS:528:DyaK1MXltFeqtQ%3D%3D Occurrence Handle9916135 Occurrence Handle407888 Occurrence Handle10.1172/JCI5487

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. RO Hynes (2002) ArticleTitleA reevaluation of integrins as regulators of angiogenesis Nat Med 8 918–21 Occurrence Handle1:CAS:528:DC%2BD38Xms1ais7g%3D Occurrence Handle12205444 Occurrence Handle10.1038/nm0902-918

    Article  CAS  PubMed  Google Scholar 

  34. J Folkman (1972) ArticleTitleAnti-angiogenesis: new concept for therapy of solid tumors Ann Surg 175 409–16 Occurrence Handle1:STN:280:DyaE3s%2FitV2gtA%3D%3D Occurrence Handle5077799 Occurrence Handle1355186 Occurrence Handle10.1097/00000658-197203000-00014

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. J Folkman (1995) ArticleTitleAngiogenesis in cancer, vascular, rheumatoid and other disease Nat Med 1 27–31 Occurrence Handle1:CAS:528:DyaK2MXjs1KnsLk%3D Occurrence Handle7584949 Occurrence Handle10.1038/nm0195-27

    Article  CAS  PubMed  Google Scholar 

  36. N Ferrara (2000) ArticleTitleVascular endothelial growth factor and the regulation of angiogenesis Recent Prog Horm Res 55 15–35 Occurrence Handle1:CAS:528:DC%2BD3MXitVGqsrs%3D Occurrence Handle11036931

    CAS  PubMed  Google Scholar 

  37. RG Tilton KC Chang WS LeJeune CC Stephan TA Brock JR Williamson (1999) ArticleTitleRole for nitric oxide in the hyperpermeability and hemodynamic changes induced by intravenous VEGF Invest Ophthalmol Vis Sci 40 689–96 Occurrence Handle1:STN:280:DyaK1M7msFaqtw%3D%3D Occurrence Handle10067972

    CAS  PubMed  Google Scholar 

  38. C Suri PF Jones S Patan S Bartunkova PC Maisonpierre S Davis et al. (1996) ArticleTitleRequisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis Cell 87 1171–80 Occurrence Handle1:CAS:528:DyaK2sXit1GhtQ%3D%3D Occurrence Handle8980224 Occurrence Handle10.1016/S0092-8674(00)81813-9

    Article  CAS  PubMed  Google Scholar 

  39. PC Maisonpierre C Suri PF Jones S Bartunkova SJ Wiegand C Radziejewski et al. (1997) ArticleTitleAngiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis Science 277 55–60 Occurrence Handle1:CAS:528:DyaK2sXksVyhu78%3D Occurrence Handle9204896 Occurrence Handle10.1126/science.277.5322.55

    Article  CAS  PubMed  Google Scholar 

  40. AS Woolf HT Yuan (2001) ArticleTitleAngiopoietin growth factors and Tie receptor tyrosine kinases in renal vascular development Pediatr Nephrol 16 177–84 Occurrence Handle1:STN:280:DC%2BD3M7lvV2jtw%3D%3D Occurrence Handle11261688 Occurrence Handle10.1007/s004670000509

    Article  CAS  PubMed  Google Scholar 

  41. MS O'Reilly T Boehm Y Shing N Fukai G Vasios WS Lane et al. (1997) ArticleTitleEndostatin: an endogenous inhibitor of angiogenesis and tumor growth Cell 88 277–85 Occurrence Handle9008168 Occurrence Handle10.1016/S0092-8674(00)81848-6

    Article  PubMed  Google Scholar 

  42. MS O'Reilly L Holmgren Y Shing C Chen RA Rosenthal M Moses et al. (1994) ArticleTitleAngiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma [see comments Cell 79 315–28 Occurrence Handle7525077 Occurrence Handle10.1016/0092-8674(94)90200-3

    Article  PubMed  Google Scholar 

  43. R Ramchandran M Dhanabal R Volk MJ Waterman M Segal H Lu et al. (1999) ArticleTitleAntiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin Biochem Biophys Res Commun 255 735–9 Occurrence Handle1:CAS:528:DyaK1MXhtlCiu7s%3D Occurrence Handle10049780 Occurrence Handle10.1006/bbrc.1999.0248

    Article  CAS  PubMed  Google Scholar 

  44. PC Colorado A Torre G Kamphaus Y Maeshima H Hopfer K Takahashi et al. (2000) ArticleTitleAnti-angiogenic cues from vascular basement membrane collagen Cancer Res 60 2520–6 Occurrence Handle1:CAS:528:DC%2BD3cXjtV2qtLk%3D Occurrence Handle10811134

    CAS  PubMed  Google Scholar 

  45. GD Kamphaus PC Colorado DJ Panka H Hopfer R Ramchandran A Torre et al. (2000) ArticleTitleCanstatin, a novel matrix-derived inhibitor of angiogenesis and tumor growth J Biol Chem 275 1209–15 Occurrence Handle1:CAS:528:DC%2BD3cXntlensw%3D%3D Occurrence Handle10625665 Occurrence Handle10.1074/jbc.275.2.1209

    Article  CAS  PubMed  Google Scholar 

  46. Y Maeshima PC Colorado A Torre KA Holthaus JA Grunkemeyer MB Ericksen et al. (2000) ArticleTitleDistinct antitumor properties of a type IV collagen domain derived from basement membrane J Biol Chem 275 21340–8 Occurrence Handle1:CAS:528:DC%2BD3cXkvFGisrw%3D Occurrence Handle10766752 Occurrence Handle10.1074/jbc.M001956200

    Article  CAS  PubMed  Google Scholar 

  47. E Petitclerc A Boutaud A Prestayko J Xu Y Sado Y Ninomiya et al. (2000) ArticleTitleNew functions for non-collagenous domains of human collagen type IV. Novel integrin ligands inhibiting angiogenesis and tumor growth in vivo J Biol Chem 275 8051–61 Occurrence Handle1:CAS:528:DC%2BD3cXitVyltLs%3D Occurrence Handle10713126 Occurrence Handle10.1074/jbc.275.11.8051

    Article  CAS  PubMed  Google Scholar 

  48. M Mongiat SM Sweeney JD San Antonio J Fu RV Iozzo (2003) ArticleTitleEndorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan J Biol Chem 278 4238–49 Occurrence Handle1:CAS:528:DC%2BD3sXot1yksg%3D%3D Occurrence Handle12435733 Occurrence Handle10.1074/jbc.M210445200

    Article  CAS  PubMed  Google Scholar 

  49. DJ Prockop KI Kivirikko (1995) ArticleTitleCollagens: molecular biology, diseases, and potentials for therapy Annu Rev Biochem 64 403–34 Occurrence Handle1:CAS:528:DyaK2MXmsl2qsbg%3D Occurrence Handle7574488 Occurrence Handle10.1146/annurev.bi.64.070195.002155

    Article  CAS  PubMed  Google Scholar 

  50. JA Madri (1997) ArticleTitleExtracellular matrix modulation of vascular cell behaviour Transpl Immunol 5 179–83 Occurrence Handle1:STN:280:DyaK1c%2Fms1ejsQ%3D%3D Occurrence Handle9402683 Occurrence Handle10.1016/S0966-3274(97)80035-4

    Article  CAS  PubMed  Google Scholar 

  51. M Paulsson (1992) ArticleTitleBasement membrane proteins: structure, assembly, and cellular interactions Crit Rev Biochem Mol Biol 27 93–127 Occurrence Handle1:CAS:528:DyaK38XltlOrug%3D%3D Occurrence Handle1309319 Occurrence Handle10.3109/10409239209082560

    Article  CAS  PubMed  Google Scholar 

  52. BG Hudson ST Reeders K Tryggvason (1993) ArticleTitleType IV collagen: structure, gene organization, and role in human diseases. Molecular basis of Goodpasture and Alport syndromes and diffuse leiomyomatosis J Biol Chem 268 26033–6 Occurrence Handle1:CAS:528:DyaK3sXmsVKrtLw%3D Occurrence Handle8253711

    CAS  PubMed  Google Scholar 

  53. CE Kashtan (1998) ArticleTitleAlport syndrome and thin glomerular basement membrane disease J Am Soc Nephrol 9 1736–50 Occurrence Handle1:STN:280:DyaK1czpsVeltA%3D%3D Occurrence Handle9727383

    CAS  PubMed  Google Scholar 

  54. R Kalluri MJ Sun BG Hudson EG Neilson (1996) ArticleTitleThe Goodpasture autoantigen. Structural delineation of two immunologically privileged epitopes on alpha3(IV) chain of type IV collagen J Biol Chem 271 9062–8 Occurrence Handle1:CAS:528:DyaK28Xitlentb0%3D Occurrence Handle8621555 Occurrence Handle10.1074/jbc.271.15.9062

    Article  CAS  PubMed  Google Scholar 

  55. T Hellmark M Segelmark C Unger H Burkhardt J Saus J Wieslander (1999) ArticleTitleIdentification of a clinically relevant immunodominant region of collagen IV in Goodpasture disease [see comments Kidney Int 55 936–44 Occurrence Handle1:CAS:528:DyaK1MXhvVSntb8%3D Occurrence Handle10027930 Occurrence Handle10.1046/j.1523-1755.1999.055003936.x

    Article  CAS  PubMed  Google Scholar 

  56. T Hellmark H Burkhardt J Wieslander (1999) ArticleTitleGoodpasture disease. Characterization of a single conformational epitope as the target of pathogenic autoantibodies J Biol Chem 274 25862–8 Occurrence Handle1:CAS:528:DyaK1MXmtVWhtrw%3D Occurrence Handle10464328 Occurrence Handle10.1074/jbc.274.36.25862

    Article  CAS  PubMed  Google Scholar 

  57. KO Netzer A Leinonen A Boutaud DB Borza P Todd S Gunwar et al. (1999) ArticleTitleThe goodpasture autoantigen. Mapping the major conformational epitope(s) of alpha3(iv) collagen to residues 17–31 and 127–141 of the nc1 domain [In Process Citation J Biol Chem 274 11267–74 Occurrence Handle1:CAS:528:DyaK1MXis1Gmtrc%3D Occurrence Handle10196215 Occurrence Handle10.1074/jbc.274.16.11267

    Article  CAS  PubMed  Google Scholar 

  58. J Han N Ohno S Pasco JC Monboisse JP Borel NA Kefalides (1997) ArticleTitleA cell binding domain from the alpha3 chain of type IV collagen inhibits proliferation of melanoma cells J Biol Chem 272 20395–401 Occurrence Handle1:CAS:528:DyaK2sXlsFKgt7s%3D Occurrence Handle9252346 Occurrence Handle10.1074/jbc.272.33.20395

    Article  CAS  PubMed  Google Scholar 

  59. TA Shahan Z Ziaie S Pasco A Fawzi G Bellon JC Monboisse et al. (1999) ArticleTitleIdentification of CD47/integrin-associated protein and alpha(v)beta3 as two receptors for the alpha3(IV) chain of type IV collagen on tumor cells Cancer Res 59 4584–90 Occurrence Handle1:CAS:528:DyaK1MXmtVKksbc%3D Occurrence Handle10493512

    CAS  PubMed  Google Scholar 

  60. Y Maeshima PC Colorado R Kalluri (2000) ArticleTitleTwo RGD-independent alpha vbeta 3 integrin binding sites on tumstatin regulate distinct anti-tumor properties J Biol Chem 275 23745–50 Occurrence Handle1:CAS:528:DC%2BD3cXls12murk%3D Occurrence Handle10837460 Occurrence Handle10.1074/jbc.C000186200

    Article  CAS  PubMed  Google Scholar 

  61. Y Maeshima M Manfredi C Reimer KA Holthaus H Hopfer BR Chandamuri et al. (2001) ArticleTitleIdentification of the anti-angiogenic site within vascular basement membrane-derived tumstatin J Biol Chem 276 15240–8 Occurrence Handle1:CAS:528:DC%2BD3MXjs1Ortrc%3D Occurrence Handle11278365 Occurrence Handle10.1074/jbc.M007764200

    Article  CAS  PubMed  Google Scholar 

  62. Y Maeshima UL Yerramalla M Dhanabal KA Holthaus S Barbashov S Kharbanda et al. (2001) ArticleTitleExtracellular matrix-derived peptide binds to alpha(v)beta(3) integrin and inhibits angiogenesis J Biol Chem 276 31959–68 Occurrence Handle1:CAS:528:DC%2BD3MXms1Smtro%3D Occurrence Handle11399763 Occurrence Handle10.1074/jbc.M103024200

    Article  CAS  PubMed  Google Scholar 

  63. EJ Brown SL Schreiber (1996) ArticleTitleA signaling pathway to translational control Cell 86 517–20 Occurrence Handle1:CAS:528:DyaK28Xltleqtrk%3D Occurrence Handle8752206 Occurrence Handle10.1016/S0092-8674(00)80125-7

    Article  CAS  PubMed  Google Scholar 

  64. M Bushell L McKendrick RU Janicke MJ Clemens SJ Morley (1999) ArticleTitleCaspase-3 is necessary and sufficient for cleavage of protein synthesis eukaryotic initiation factor 4G during apoptosis FEBS Lett 451 332–6 Occurrence Handle1:CAS:528:DyaK1MXjs1Sitrg%3D Occurrence Handle10371215 Occurrence Handle10.1016/S0014-5793(99)00614-6

    Article  CAS  PubMed  Google Scholar 

  65. AC Gingras B Raught N Sonenberg (2001) ArticleTitleRegulation of translation initiation by FRAP/mTOR Genes Dev 15 807–26 Occurrence Handle1:CAS:528:DC%2BD3MXivVams7k%3D Occurrence Handle11297505 Occurrence Handle10.1101/gad.887201

    Article  CAS  PubMed  Google Scholar 

  66. Y Maeshima A Sudhakar JC Lively K Ueki S Kharbanda CR Kahn et al. (2002) ArticleTitleTumstatin, an endothelial cell-specific inhibitor of protein synthesis Science 295 140–3 Occurrence Handle1:CAS:528:DC%2BD38XksVCktA%3D%3D Occurrence Handle11778052 Occurrence Handle10.1126/science.1065298

    Article  CAS  PubMed  Google Scholar 

  67. K Vuori (1998) ArticleTitleIntegrin signaling: tyrosine phosphorylation events in focal adhesions J Membr Biol 165 191–9 Occurrence Handle1:STN:280:DyaK1cvktVOntw%3D%3D Occurrence Handle9767673 Occurrence Handle10.1007/s002329900433

    Article  CAS  PubMed  Google Scholar 

  68. E Ruoslahti (1999) ArticleTitleFibronectin and its integrin receptors in cancer Adv Cancer Res 76 1–20 Occurrence Handle1:CAS:528:DyaK1MXjtFKgsL4%3D Occurrence Handle10218097 Occurrence Handle10.1016/S0065-230X(08)60772-1

    Article  CAS  PubMed  Google Scholar 

  69. HC Chen JL Guan (1994) ArticleTitleAssociation of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase Proc Natl Acad Sci USA 91 10148–52 Occurrence Handle1:CAS:528:DyaK2cXmslGjurk%3D Occurrence Handle7937853 Occurrence Handle44975 Occurrence Handle10.1073/pnas.91.21.10148

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  70. GJ Brunn CC Hudson A Sekulic JM Williams H Hosoi PJ Houghton et al. (1997) ArticleTitlePhosphorylation of the translational repressor PHAS-I by the mammalian target of rapamycin Science 277 99–101 Occurrence Handle1:CAS:528:DyaK2sXksVygsLw%3D Occurrence Handle9204908 Occurrence Handle10.1126/science.277.5322.99

    Article  CAS  PubMed  Google Scholar 

  71. AC Gingras SP Gygi B Raught RD Polakiewicz RT Abraham MF Hoekstra et al. (1999) ArticleTitleRegulation of 4E-BP1 phosphorylation: a novel two-step mechanism Genes Dev 13 1422–37 Occurrence Handle1:CAS:528:DyaK1MXjvVahsLc%3D Occurrence Handle10364159 Occurrence Handle316780 Occurrence Handle10.1101/gad.13.11.1422

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  72. A Pause GJ Belsham AC Gingras O Donze TA Lin JC Lawrence SuffixJr et al. (1994) ArticleTitleInsulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5′-cap function Nature 371 762–7 Occurrence Handle1:CAS:528:DyaK2cXmvFehur8%3D Occurrence Handle7935836 Occurrence Handle10.1038/371762a0

    Article  CAS  PubMed  Google Scholar 

  73. Y Hamano M Zeisberg H Sugimoto JC Lively Y Maeshima C Yang et al. (2003) ArticleTitlePhysiological levels of tumstatin, a fragment of collagen IV alpha3 chain, are generated by MMP-9 proteolysis and suppress angiogenesis via alphaV beta3 integrin Cancer Cell 3 589–601 Occurrence Handle1:CAS:528:DC%2BD3sXltlSmsLo%3D Occurrence Handle12842087 Occurrence Handle2775452 Occurrence Handle10.1016/S1535-6108(03)00133-8

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  74. M Sund Y Hamano H Sugimoto A Sudhakar M Soubasakos U Yerramalla et al. (2005) ArticleTitleFunction of endogenous inhibitors of angiogenesis as endothelium-specific tumor suppressors Proc Natl Acad Sci USA 102 2934–9 Occurrence Handle1:CAS:528:DC%2BD2MXitVSktrg%3D Occurrence Handle15710885 Occurrence Handle549486 Occurrence Handle10.1073/pnas.0500180102

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  75. E Ritz I Rychlik F Locatelli S Halimi (1999) ArticleTitleEnd-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions Am J Kidney Dis 34 795–808 Occurrence Handle1:STN:280:DC%2BD3c%2FjtVWqsg%3D%3D Occurrence Handle10561134 Occurrence Handle10.1016/S0272-6386(99)70035-1

    Article  CAS  PubMed  Google Scholar 

  76. R Osterby HH Parving G Nyberg E Hommel HE Jorgensen H Lokkegaard et al. (1988) ArticleTitleA strong correlation between glomerular filtration rate and filtration surface in diabetic nephropathy Diabetologia 31 265–70 Occurrence Handle1:STN:280:DyaL1c3osVWjtg%3D%3D Occurrence Handle3396784

    CAS  PubMed  Google Scholar 

  77. H Makino Y Yamasaki T Haramoto K Shikata K Hironaka Z Ota et al. (1993) ArticleTitleUltrastructural changes of extracellular matrices in diabetic nephropathy revealed by high resolution scanning and immunoelectron microscopy Lab Invest 68 45–55 Occurrence Handle1:STN:280:DyaK3s7ktVejsw%3D%3D Occurrence Handle8423676

    CAS  PubMed  Google Scholar 

  78. H Makino N Kashihara H Sugiyama K Kanao T Sekikawa K Okamoto et al. (1996) ArticleTitlePhenotypic modulation of the mesangium reflected by contractile proteins in diabetes Diabetes 45 488–95 Occurrence Handle1:CAS:528:DyaK28Xjs1Gjtbc%3D Occurrence Handle8603771 Occurrence Handle10.2337/diab.45.4.488

    Article  CAS  PubMed  Google Scholar 

  79. K Sharma FN Ziyadeh (1995) ArticleTitleHyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator Diabetes 44 1139–46 Occurrence Handle1:CAS:528:DyaK2MXotlGhu74%3D Occurrence Handle7556948 Occurrence Handle10.2337/diab.44.10.1139

    Article  CAS  PubMed  Google Scholar 

  80. A Flyvbjerg (2000) ArticleTitlePutative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease Diabetologia 43 1205–23 Occurrence Handle1:CAS:528:DC%2BD3cXmslOiurY%3D Occurrence Handle11079738 Occurrence Handle10.1007/s001250051515

    Article  CAS  PubMed  Google Scholar 

  81. ME Cooper D Vranes S Youssef SA Stacker AJ Cox B Rizkalla et al. (1999) ArticleTitleIncreased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes Diabetes 48 2229–39 Occurrence Handle1:CAS:528:DyaK1MXntVSlsb4%3D Occurrence Handle10535459 Occurrence Handle10.2337/diabetes.48.11.2229

    Article  CAS  PubMed  Google Scholar 

  82. K Tsuchida Z Makita S Yamagishi T Atsumi H Miyoshi S Obara et al. (1999) ArticleTitleSuppression of transforming growth factor beta and vascular endothelial growth factor in diabetic nephropathy in rats by a novel advanced glycation end product inhibitor, OPB-9195 Diabetologia 42 579–88 Occurrence Handle1:CAS:528:DyaK1MXislaisL8%3D Occurrence Handle10333051 Occurrence Handle10.1007/s001250051198

    Article  CAS  PubMed  Google Scholar 

  83. AS de Vriese RG Tilton M Elger CC Stephan W Kriz NH Lameire (2001) ArticleTitleAntibodies against vascular endothelial growth factor improve early renal dysfunction in experimental diabetes J Am Soc Nephrol 12 993–1000 Occurrence Handle1:CAS:528:DC%2BD3MXjvVCgtLY%3D Occurrence Handle11316858

    CAS  PubMed  Google Scholar 

  84. A Flyvbjerg F Dagnaes-Hansen AS De Vriese BF Schrijvers RG Tilton R Rasch (2002) ArticleTitleAmelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody Diabetes 51 3090–4 Occurrence Handle1:CAS:528:DC%2BD38XnslGhsLc%3D Occurrence Handle12351452 Occurrence Handle10.2337/diabetes.51.10.3090

    Article  CAS  PubMed  Google Scholar 

  85. JR Nyengaard R Rasch (1993) ArticleTitleThe impact of experimental diabetes mellitus in rats on glomerular capillary number and sizes Diabetologia 36 189–194 Occurrence Handle1:STN:280:DyaK3s3hsF2ltg%3D%3D Occurrence Handle8462766 Occurrence Handle10.1007/BF00399948

    Article  CAS  PubMed  Google Scholar 

  86. Y Yamamoto Y Maeshima H Kitayama S Kitamura Y Takazawa H Sugiyama et al. (2004) ArticleTitleTumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy Diabetes 53 1831–40 Occurrence Handle1:CAS:528:DC%2BD2cXlslWgtLY%3D Occurrence Handle15220208 Occurrence Handle10.2337/diabetes.53.7.1831

    Article  CAS  PubMed  Google Scholar 

  87. D Senthil GG Choudhury C McLaurin BS Kasinath (2003) ArticleTitleVascular endothelial growth factor induces protein synthesis in renal epithelial cells: a potential role in diabetic nephropathy Kidney Int 64 468–79 Occurrence Handle1:CAS:528:DC%2BD3sXmsFyku74%3D Occurrence Handle12846742 Occurrence Handle10.1046/j.1523-1755.2003.00135.x

    Article  CAS  PubMed  Google Scholar 

  88. M Kestila U Lenkkeri M Mannikko J Lamerdin P McCready H Putaala et al. (1998) ArticleTitlePositionally cloned gene for a novel glomerular protein – nephrin – is mutated in congenital nephrotic syndrome Mol Cell 1 575–82 Occurrence Handle1:CAS:528:DyaK1cXit1Gisbw%3D Occurrence Handle9660941 Occurrence Handle10.1016/S1097-2765(00)80057-X

    Article  CAS  PubMed  Google Scholar 

  89. P Aaltonen P Luimula E Astrom T Palmen T Gronholm E Palojoki et al. (2001) ArticleTitleChanges in the expression of nephrin gene and protein in experimental diabetic nephropathy Lab Invest 81 1185–90 Occurrence Handle1:CAS:528:DC%2BD3MXnt1Sntrg%3D Occurrence Handle11555666 Occurrence Handle10.1038/labinvest.3780332

    Article  CAS  PubMed  Google Scholar 

  90. F Bonnet ME Cooper H Kawachi TJ Allen G Boner Z Cao (2001) ArticleTitleIrbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension Diabetologia 44 874–7 Occurrence Handle1:CAS:528:DC%2BD3MXks1Ort7c%3D Occurrence Handle11508272 Occurrence Handle10.1007/s001250100546

    Article  CAS  PubMed  Google Scholar 

  91. S Doublier G Salvidio E Lupia V Ruotsalainen D Verzola G Deferrari et al. (2003) ArticleTitleNephrin expression is reduced in human diabetic nephropathy: evidence for a distinct role for glycated albumin and angiotensin II Diabetes 52 1023–30 Occurrence Handle1:CAS:528:DC%2BD3sXislOns7c%3D Occurrence Handle12663475 Occurrence Handle10.2337/diabetes.52.4.1023

    Article  CAS  PubMed  Google Scholar 

  92. V Eremina M Sood J Haigh A Nagy G Lajoie N Ferrara et al. (2003) ArticleTitleGlomerular-specific alterations of VEGF-A expression lead to distinct congenital and acquired renal diseases J Clin Invest 111 707–16 Occurrence Handle1:CAS:528:DC%2BD3sXhvFenurs%3D Occurrence Handle12618525 Occurrence Handle151905 Occurrence Handle10.1172/JCI17423

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  93. K Ichinose Y Maeshima Y Yamamoto H Kitayama Y Takazawa K Hirokoshi et al. (2005) ArticleTitleAnti-angiogenic endostatin peptide ameliorates renal alterations in the early stage of type 1 diabetic nephropathy model Diabetes 54 2891–2903 Occurrence Handle1:CAS:528:DC%2BD2MXhtV2rs77F Occurrence Handle16186390 Occurrence Handle10.2337/diabetes.54.10.2891

    Article  CAS  PubMed  Google Scholar 

  94. A Sudhakar H Sugimoto C Yang J Lively M Zeisberg R Kalluri (2003) ArticleTitleHuman tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins Proc Natl Acad Sci USA 100 4766–71 Occurrence Handle1:CAS:528:DC%2BD3sXjt12nsLc%3D Occurrence Handle12682293 Occurrence Handle153630 Occurrence Handle10.1073/pnas.0730882100

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  95. F Niimura PA Labosky J Kakuchi S Okubo H Yoshida T Oikawa et al. (1995) ArticleTitleGene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation J Clin Invest 96 2947–54 Occurrence Handle1:CAS:528:DyaK28XmtVenug%3D%3D Occurrence Handle8675666 Occurrence Handle186006 Occurrence Handle10.1172/JCI118366

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  96. S Tsuchida T Matsusaka X Chen S Okubo F Niimura H Nishimura et al. (1998) ArticleTitleMurine double nullizygotes of the angiotensin type 1A and 1B receptor genes duplicate severe abnormal phenotypes of angiotensinogen nullizygotes J Clin Invest 101 755–60 Occurrence Handle1:CAS:528:DyaK1cXht1WrsbY%3D Occurrence Handle9466969 Occurrence Handle508622 Occurrence Handle10.1172/JCI1899

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  97. MI Oliverio HS Kim M Ito T Le L Audoly CF Best et al. (1998) ArticleTitleReduced growth, abnormal kidney structure, and type 2 (AT2) angiotensin receptor-mediated blood pressure regulation in mice lacking both AT1A and AT1B receptors for angiotensin II Proc Natl Acad Sci USA 95 15496–501 Occurrence Handle1:CAS:528:DyaK1MXhvFartQ%3D%3D Occurrence Handle9860997 Occurrence Handle28071 Occurrence Handle10.1073/pnas.95.26.15496

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  98. S Kiyama F Nanishi S Tomooka S Okuda K Onoyama M Fujishima (1994) ArticleTitleInhibitory effects of antihypertensive drugs on mesangial cell proliferation after anti-thymocyte serum (ATS)-induced mesangiolysis in spontaneously hypertensive rats Life Sci 54 1891–900 Occurrence Handle1:CAS:528:DyaK2cXktVSms7k%3D Occurrence Handle8196507 Occurrence Handle10.1016/0024-3205(94)90147-3

    Article  CAS  PubMed  Google Scholar 

  99. H Peters WA Border NA Noble (2000) ArticleTitleAngiotensin II blockade and low-protein diet produce additive therapeutic effects in experimental glomerulonephritis Kidney Int 57 1493–501 Occurrence Handle1:CAS:528:DC%2BD3cXjtVOrt7c%3D Occurrence Handle10760085 Occurrence Handle10.1046/j.1523-1755.2000.00994.x

    Article  CAS  PubMed  Google Scholar 

  100. UO Wenzel F Thaiss U Helmchen RA Stahl G Wolf (2002) ArticleTitleAngiotensin II infusion ameliorates the early phase of a mesangioproliferative glomerulonephritis Kidney Int 61 1020–9 Occurrence Handle1:CAS:528:DC%2BD38Xit1agu7k%3D Occurrence Handle11849457 Occurrence Handle10.1046/j.1523-1755.2002.00192.x

    Article  CAS  PubMed  Google Scholar 

  101. W Kriz B Hahnel H Hosser T Ostendorf S Gaertner B Kranzlin et al. (2003) ArticleTitlePathways to recovery and loss of nephrons in anti-Thy-1 nephritis J Am Soc Nephrol 14 1904–26 Occurrence Handle12819253 Occurrence Handle10.1097/01.ASN.0000070073.79690.57

    Article  PubMed  Google Scholar 

  102. A Shimizu Y Masuda H Kitamura M Ishizaki Y Sugisaki N Yamanaka (1998) ArticleTitleRecovery of damaged glomerular capillary network with endothelial cell apoptosis in experimental proliferative glomerulonephritis Nephron 79 206–14 Occurrence Handle1:STN:280:DyaK1czgvFOitQ%3D%3D Occurrence Handle9647502 Occurrence Handle10.1159/000045026

    Article  CAS  PubMed  Google Scholar 

  103. T Ostendorf U Kunter F Eitner A Loos H Regele D Kerjaschki et al. (1999) ArticleTitleVEGF(165) mediates glomerular endothelial repair J Clin Invest 104 913–23 Occurrence Handle1:CAS:528:DyaK1MXmsVClsbo%3D Occurrence Handle10510332 Occurrence Handle408553 Occurrence Handle10.1172/JCI6740

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  104. Y Masuda A Shimizu T Mori T Ishiwata H Kitamura R Ohashi et al. (2001) ArticleTitleVascular endothelial growth factor enhances glomerular capillary repair and accelerates resolution of experimentally induced glomerulonephritis Am J Pathol 159 599–608 Occurrence Handle1:CAS:528:DC%2BD3MXms1Witrk%3D Occurrence Handle11485918 Occurrence Handle1850560 Occurrence Handle10.1016/S0002-9440(10)61731-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  105. K Sasaki T Murohara H Ikeda T Sugaya T Shimada S Shintani et al. (2002) ArticleTitleEvidence for the importance of angiotensin II type 1 receptor in ischemia-induced angiogenesis J Clin Invest 109 603–11 Occurrence Handle1:CAS:528:DC%2BD38XitVeqtL4%3D Occurrence Handle11877468 Occurrence Handle150887 Occurrence Handle10.1172/JCI0213055

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  106. K Egami T Murohara T Shimada K Sasaki S Shintani T Sugaya et al. (2003) ArticleTitleRole of host angiotensin II type 1 receptor in tumor angiogenesis and growth J Clin Invest 112 67–75 Occurrence Handle1:CAS:528:DC%2BD3sXlt1Krt7g%3D Occurrence Handle12840060 Occurrence Handle162282 Occurrence Handle10.1172/JCI16645

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  107. Y Takazawa Y Maeshima H Kitayama Y Yamamoto H Kawachi F Shimizu et al. (2005) ArticleTitleInfusion of angiotensin II reduces loss of glomerular capillary area in the early phase of anti-Thy-1.1 nephritis possibly via regulating angiogenesis-associated factors Kidney Int 68 704–22 Occurrence Handle1:CAS:528:DC%2BD2MXpt1WmtL4%3D Occurrence Handle16014048 Occurrence Handle10.1111/j.1523-1755.2005.00449.x

    Article  CAS  PubMed  Google Scholar 

  108. B Jackson L Franze E Sumithran CI Johnston (1990) ArticleTitlePharmacologic nephrectomy with chronic angiotensin converting enzyme inhibitor treatment in renovascular hypertension in the rat J Lab Clin Med 115 21–7 Occurrence Handle1:CAS:528:DyaK3cXhtFWku74%3D Occurrence Handle2299253

    CAS  PubMed  Google Scholar 

  109. H Fujinaka Y Miyazaki T Matsusaka H Yoshida AB Fogo T Inagami et al. (2000) ArticleTitleSalutary role for angiotensin in partial urinary tract obstruction Kidney Int 58 2018–27 Occurrence Handle1:STN:280:DC%2BD3M%2FivFSksQ%3D%3D Occurrence Handle11044222 Occurrence Handle10.1111/j.1523-1755.2000.00374.x

    Article  CAS  PubMed  Google Scholar 

  110. UO Wenzel G Wolf F Thaiss U Helmchen RA Stahl (2000) ArticleTitleRenovascular hypertension does not influence repair of glomerular lesions induced by anti-thymocyte glomerulonephritis Kidney Int 58 1135–47 Occurrence Handle1:STN:280:DC%2BD3cvotlyjsg%3D%3D Occurrence Handle10972677 Occurrence Handle10.1046/j.1523-1755.2000.00270.x

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine and Clinical Science, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, 2-5-1 Shikata-cho, Okayama, 700-8558, Japan

    Yohei Maeshima

Authors
  1. Yohei Maeshima
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yohei Maeshima.

About this article

Cite this article

Maeshima, Y. Novel therapeutic approaches for progressive renal disorders by targeting glomerular component mesangial and endothelial cells. Clin Exp Nephrol 9, 271–281 (2005). https://doi.org/10.1007/s10157-005-0388-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-005-0388-1

Key words

Search

Navigation